NATUS MEDICAL INVESTOR ALERT: Gibbs Law Group Investigates Potential Securities Law Violations
08 Février 2019 - 1:18AM
Business Wire
Gibbs Law Group is investigating claims on behalf of investors
of Natus Medical Incorporated (NASDAQ: BABY) involving possible
securities law violations. Specifically, our investigation focuses
on allegations that Natus Medical and certain of its officers
and/or directors may have engaged in unlawful business practices or
securities fraud.
To speak privately with an attorney regarding this class
action lawsuit investigation, click here.
On February 6, 2019, GlassHouse Research published a report
about Natus Medical entitled “Throw the BABY (Natus Medical Inc.)
Out with the Bathwater,” accusing the company of engaging in
deceptive accounting practices. Specifically, the GlassHouse
Research Report accused the Natus Medical’s management of
concealing approximately $18 million in “what should be
written-down inventory” in order to enhance its inventory metrics
and reported earnings. The report suggseted that Natus would likely
need to write off its obsolete inventory in 2019.
Following this news, Natus Medical shares fell significantly,
closing at $30.51 on February 7, 2019.
If you purchased or acquired shares of Natus Medical and would
like to speak privately with a securities attorney to learn more
about our investigation and your legal rights, visit our website or
contact our securities team directly at (800) 808-5294.
Gibbs Law Group represents individual and institutional
investors in securities litigation to correct abusive
corporate governance practices, breaches of fiduciary duty, and
proxy violations. The firm has recovered over a billion dollars for
its clients against some of the world’s largest corporations, and
our attorneys have received numerous honors for their work,
including “Best Lawyers in America,” “Top Plaintiff Lawyers in
California,” “Top Class Action Attorneys Under 40,” “Consumer
Protection MVP,” and “Top Cybersecurity/ Privacy Attorneys Under
40.”
This press release may constitute Attorney Advertising in some
jurisdictions under the applicable law and ethical rules.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20190207005945/en/
EILEEN EPSTEINPHONE: 510.350.9728EMAIL:
EJE@CLASSLAWGROUP.COM
PishPosh (NASDAQ:BABY)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024
PishPosh (NASDAQ:BABY)
Graphique Historique de l'Action
De Juin 2023 à Juin 2024
Real-Time news about PishPosh Inc (NASDAQ): 0 recent articles
Plus d'articles sur Natus Medical Incorporated